Literature DB >> 383476

Antiepileptic properties of clobazam, a 1-5 benzodiazepine, in man.

H Gastaut, M D Low.   

Abstract

Clobazam is a benzodiazepine with special molecular structure (its nitrogen radicals are in positions 1 and 5, rather than 1 and 4 as in all other antiepileptic benzodiazepines), and it is rapidly effective--in a matter of hours or within a few days--against all varieties of epileptic seizures in 52% of subjects treated with it. Its effects are relatively mild. Unfortunately, its outstanding antiepileptic properties are exhausted after only a few weeks in one-third of all cases. The authors discuss the potential significance of this phenomenon, and stress the urgent need for intensive study of the basic mechanism governing exhaustion of the antiepileptic properties of the benzodiazepines in general and clobazam in particular.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 383476     DOI: 10.1111/j.1528-1157.1979.tb04825.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  16 in total

Review 1.  GABA(A) receptor physiology and its relationship to the mechanism of action of the 1,5-benzodiazepine clobazam.

Authors:  Raman Sankar
Journal:  CNS Drugs       Date:  2012-03-01       Impact factor: 5.749

2.  GABAA Receptors of Cerebellar Granule Cells in Culture: Interaction with Benzodiazepines.

Authors:  Aroldo Cupello; Mario Di Braccio; Elena Gatta; Giancarlo Grossi; Periklis Nikas; Francesca Pellistri; Mauro Robello
Journal:  Neurochem Res       Date:  2013-10-12       Impact factor: 3.996

3.  Development of tolerance to anticonvulsant effect of clobazam.

Authors:  J W Allen; S Jawad; J Oxley; M Trimble
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-03       Impact factor: 10.154

4.  PharmGKB summary: clobazam pathway, pharmacokinetics.

Authors:  Rachel Huddart; J Steven Leeder; Russ B Altman; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2018-04       Impact factor: 2.089

Review 5.  Clobazam.

Authors:  Yu-tze Ng; Stephen D Collins
Journal:  Neurotherapeutics       Date:  2007-01       Impact factor: 7.620

Review 6.  Clobazam add-on therapy for drug-resistant epilepsy.

Authors:  Rebecca Bresnahan; Kirsty J Martin-McGill; John Williamson; Benedict D Michael; Anthony G Marson
Journal:  Cochrane Database Syst Rev       Date:  2019-10-22

7.  Clobazam in the treatment of epilepsy: prospective follow-up to 8 years.

Authors:  N Buchanan
Journal:  J R Soc Med       Date:  1993-07       Impact factor: 5.344

8.  No effect of food intake on clobazam absorption.

Authors:  B Cenraud; M Guyot; R H Levy; A Brachet-Liermain; P L Morselli; T A Moreland; P Loiseau
Journal:  Br J Clin Pharmacol       Date:  1983-12       Impact factor: 4.335

9.  Clobazam as adjunctive treatment in refractory epilepsy.

Authors:  J W Allen; J Oxley; M M Robertson; M R Trimble; A Richens; S S Jawad
Journal:  Br Med J (Clin Res Ed)       Date:  1983-04-16

10.  Clobazam plasma concentrations: pharmacokinetic study in healthy volunteers and data in epileptic patients.

Authors:  G Tedeschi; R Riva; A Baruzzi
Journal:  Br J Clin Pharmacol       Date:  1981-06       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.